Current role of endovascular therapy in Marfan patients with previous aortic surgery.
The Marfan syndrome is a heritable disorder of the connective tissue which affects the cardiovascular, ocular, and skeletal system. The cardiovascular manifestation with aortic root dilatation, aortic valve regurgitation, and aortic dissection has a prevalence of 60% to 90% and determines the premature death of these patients. Thirty-four percent of the patients with Marfan syndrome will have serious cardiovascular complications requiring surgery in the first 10 years after diagnosis. Before aortic surgery became available, the majority of the patients died by the age of 32 years. Introduction in the aortic surgery techniques caused an increase of the 10 year survival rate up to 97%. The purpose of this article is to give an overview about the feasibility and outcome of stent-graft placement in the descending thoracic aorta in Marfan patients with previous aortic surgery.
Akin
Ibrahim
I
Department of Medicine, Division of Cardiology at the University Hospital Rostock, Rostock School of Medicine, Ernst-Heydemann-Str. 6, 18057 Rostock, Germany.
Kische
Stephan
S
Rehders
Tim C
TC
Chatterjee
Tushar
T
Schneider
Henrik
H
Körber
Thomas
T
Nienaber
Christoph A
CA
Ince
Hüseyin
H
D001018:Aortic Diseases / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation; D004108:Dilatation, Pathologic; D006801:Humans; D008382:Marfan Syndrome / Q000601:surgery*; D015607:Stents